Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • Medication recall for one lot of paroxetine 30 mg tablets from Zydus Pharmaceuticals

    by
    • Optum Workers' Comp
    | Sep 22, 2017
    Tag Icon
    Medication Recall
    Zydus Pharmaceuticals USA Inc, the United States division of Cadila Healthcare has voluntarily recalled 44,800 bottles of paroxetine 30 mg tablets from the US market. Zydus is recalling the medication due to the presence of foreign tablets, reported to be another medication (risperidone 0.25 mg tablets), found in the bottles.


  • Pharmacy Resource Guide now available

    by
    • Optum Workers' Comp
    | Sep 21, 2017
    Tag Icon
    Pharmacy Fee Schedules, Workers' Compensation
    We are pleased to share our 2017 Pharmacy Resource Guide. Inside you will find a state-by-state guide to the pharmacy fee schedule and jurisdictional maps highlighting key workers’ compensation laws and regulations.


  • Virginia finalizes regulatory activity to control opioid utilization

    by
    • Optum Workers' Comp
    | Sep 20, 2017
    Tag Icon
    PDMPs, Chronic Pain, Opioids
    The Virginia Board of Medicine and Board of Pharmacy recently implemented regulatory changes aimed at controlling opioid analgesic utilization through procedures for both prescribing and dispensing. The Board of Medicine amended a finalized emergency rule, similar to other states, putting in place prescribing controls on opioid analgesics utilized when treating acute pain. The emergency regulation also provides specific treatment protocols and requirements for chronic pain, including requirements to check the state PDMP program and complete a medical exam of the patient.


  • Ongoing opioid and formulary discussion in Arkansas

    by
    • Optum Workers' Comp
    | Sep 15, 2017
    Tag Icon
    Formularies, Opioids
    One trend we have seen this year in numerous states is an attempt to control opioid utilization in workers’ compensation through development of state-specific formularies and/or treatment guidelines. One such jurisdiction we have been working with during their development of a drug formulary, which could potentially contain opioid-specific prescribing restrictions, is Arkansas.






Subscribe

Stay informed by signing up to receive newsletters, alerts, insights and videos.
You can customize your content preferences after you subscribe.